Tempus AI, Inc. (TEM) research
Tempus AI, Inc.- Sector
- Life Sciences Tools & Services
- Last price
- $76.63
- As of
Tempus AI, Inc. (TEM): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-30.
As of . Source: SEC EDGAR filings for TEM. Method and limitations.
Share the TEM intelligence card
See the full TEM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TEM on one page. Preview it with sample data, then open it live with a free account.
Preview the TEM dossierActive signals for TEM
- highCONSENSUS_SELL
5 tracked funds reduced TEM this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased TEM this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +661% to TEM (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +303% to TEM (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +55% to TEM (2026Q2)
FREE, NO ACCOUNT
Every signal on TEM, as it fires
You are seeing 5 of 23 signals recorded on TEM since 2026-05-30.
The five above landed across 2 days. The other 18 were recorded on 3 other days. 16 of the 23 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TEM (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 88023B103 · 2026Q2 | $145.5M | 0.02% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 88023B103 · 2026Q2 | $8.5M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 88023B103 · 2026Q2 | $3.7M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TEM
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
TEM against its peers
TEM's operating margin of -19.9% ranks in the 40th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | TEM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.3B USD | 1.2B USD | 52 | 25 |
| Gross margin | n/a | 57.3% | n/a | 12 |
| Operating margin | -19.9% | 0.6% | 40 | 23 |
| Net margin | -19.3% | -0.3% | 37 | 25 |
| Return on equity | -49.9% | -2.5% | 22 | 24 |
| P / E | n/a | 41.0x | n/a | 12 |
Peers (25): MEDP, CRL, TXG, TECH, RGEN, AVTR, BRKR, MTD, ILMN, WAT, IQV, SHC, A, ADPT, ABCL, FTRE, DHR, MRVI, TMO, DNA, PACB, CTKB, MLAB, OABI, CDXS. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (TEM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more TEM signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TEMand get the insider, 13F, options, and confluence read in one view.